[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $hrmy Harmony Biosciences announces initiation of first-in-human study for a new narcolepsy drug, BP1.15205. The company also presented positive Phase X data for EPX-100 in Dravet Syndrome. ### About $hrmy Harmony Biosciences is a pharmaceutical company focused on developing and commercializing therapies for neurological disorders. ### Insights - $hrmy sentiment is up XX% from the previous week. - $hrmy engagements is up XXXXX% from the previous week. ### Engagements: XXXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$hrmy/time-series/interactions.tsv) Current Value: XXXXXX Daily Average: XXXXX X Week: XXXXX +29% X Month: XXXXXX -XX% X Months: XXXXXXX +35% X Year: XXXXXXXXX -XXXX% 1-Year High: XXXXXX on 2025-02-25 1-Year Low: XX on 2025-12-06 Engagements by network (24h): X: XXXXXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$hrmy/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XX +6.30% X Month: XXX +7% X Months: XXXXX +94% X Year: XXXXX +127% 1-Year High: XXX on 2025-06-29 1-Year Low: X on 2025-12-06 Mentions by network (24h): X: XXX ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$hrmy/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $hrmy in the last XX hours which is up XXX% from XX in the previous XX hours Daily Average: XX X Week: XX +6.80% X Month: XXX +26% X Months: XXX +190% X Year: XXXXX +178% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-12-06 The most influential creators that mention $hrmy in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@lifesciencerpt](/creator/twitter/lifesciencerpt) | X | XXXXX | X | XXX | | [@ChartMill](/creator/twitter/ChartMill) | X | XXXXXX | X | XX | | [@seedytx19](/creator/twitter/seedytx19) | X | XXXXX | X | XX | | [@PerryGlasenberg](/creator/twitter/PerryGlasenberg) | X | XX | X | XX | | [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X | XXXXX | X | XX | | [@TrendingShared](/creator/twitter/TrendingShared) | X | XX | X | XX | | [@fundmyfund](/creator/twitter/fundmyfund) | X | XXXXX | X | XX | | [@Alerts_Bullish](/creator/twitter/Alerts_Bullish) | X | XXX | X | XX | | [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X | XXXXX | X | XX | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | XX | XXXXX | X | XX | [View More](/list/creators/$hrmy/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$hrmy/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% +8% X Month: XX% -XX% X Months: XX% -XX% X Year: XX% -XX% 1-Year High: XXX% on 2024-12-11 1-Year Low: XX% on 2025-09-07 Most Supportive Themes: - Strong Q3 Revenue and Guidance Raise: (60%) Harmony Biosciences reported record Q3 revenue, exceeding expectations and raising fiscal year guidance due to strong WAKIX franchise growth. Most Critical Themes: - Patent Challenge and Competition: (25%) Concerns regarding the patent challenge for Wakix and potential competition from other drugs. - Market Volatility Concerns: (15%) Concerns about the overall market conditions and their impact on the project. ### Top $hrmy Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$HRMY -XXXX% today as Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048700480790602) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-08T15:15Z 3009 followers, XXX engagements "H&R Block $HRB provides tax preparation services in the US Canada and Australia. The stock is down XX% YTD and I recently added it to the Magic Formula portfolio. 👇 👉 $CROX $HRMY $ANF $CCSI $LNTH $YELP" [X Link](https://x.com/guru_gems/status/1998020758933766614) [@guru_gems](/creator/x/guru_gems) 2025-12-08T13:24Z XXX followers, XXX engagements "Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome $HRMY" [X Link](https://x.com/lifesciencerpt/status/1998017225156911428) [@lifesciencerpt](/creator/x/lifesciencerpt) 2025-12-08T13:10Z 6446 followers, XXX engagements "$HRMY Target price for Upcoming week💯💰👇" [X Link](https://x.com/henkletrade/status/1997942874655412613) [@henkletrade](/creator/x/henkletrade) 2025-12-08T08:14Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Harmony Biosciences announces initiation of first-in-human study for a new narcolepsy drug, BP1.15205. The company also presented positive Phase X data for EPX-100 in Dravet Syndrome.
Harmony Biosciences is a pharmaceutical company focused on developing and commercializing therapies for neurological disorders.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
X Week: XXXXX +29%
X Month: XXXXXX -XX%
X Months: XXXXXXX +35%
X Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXX on 2025-02-25
1-Year Low: XX on 2025-12-06
Engagements by network (24h): X: XXXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +6.30%
X Month: XXX +7%
X Months: XXXXX +94%
X Year: XXXXX +127%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-12-06
Mentions by network (24h): X: XXX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $hrmy in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XX
X Week: XX +6.80%
X Month: XXX +26%
X Months: XXX +190%
X Year: XXXXX +178%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-06
The most influential creators that mention $hrmy in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @lifesciencerpt | X | XXXXX | X | XXX |
| @ChartMill | X | XXXXXX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
| @PerryGlasenberg | X | XX | X | XX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @TrendingShared | X | XX | X | XX |
| @fundmyfund | X | XXXXX | X | XX |
| @Alerts_Bullish | X | XXX | X | XX |
| @NightOwlBiotech | X | XXXXX | X | XX |
| @MarcJacksonLA | XX | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +8%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-11
1-Year Low: XX% on 2025-09-07
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$HRMY -XXXX% today as Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome More Info:"
X Link @OzmosiHealth 2025-12-08T15:15Z 3009 followers, XXX engagements
"H&R Block $HRB provides tax preparation services in the US Canada and Australia. The stock is down XX% YTD and I recently added it to the Magic Formula portfolio. 👇 👉 $CROX $HRMY $ANF $CCSI $LNTH $YELP"
X Link @guru_gems 2025-12-08T13:24Z XXX followers, XXX engagements
"Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome $HRMY"
X Link @lifesciencerpt 2025-12-08T13:10Z 6446 followers, XXX engagements
"$HRMY Target price for Upcoming week💯💰👇"
X Link @henkletrade 2025-12-08T08:14Z XX followers, XX engagements
/topic/$hrmy